An Argentine company, Biogénesis Bagó, has delivered one million vaccines against foot-and-mouth disease to South Africa as part of an agreement to combat the disease affecting livestock in the country.
Biogénesis Bagó, an Argentine pharmaceutical company, recently made a significant contribution to South Africa's fight against foot-and-mouth disease by delivering one million vaccines to the country's Ministry of Agriculture. This delivery is part of a broader agreement aimed at addressing a health emergency that has critically impacted livestock treated with these vaccines for the SAT 1 and SAT 2 strains. The delivery highlights the company's commitment to international health initiatives and disease control in agriculture.
In the statement made by Rodolfo Bellinzoni, the company's Director of Operations and Innovation, he emphasized Biogénesis Bagó's extensive experience in managing health emergencies related to foot-and-mouth disease across various regions, including Latin America, Asia, and the Middle East. He reassured that they are dedicated to supporting South African authorities and local producers to restore the country's status as free from foot-and-mouth disease, indicating the long-term impact of their efforts in veterinary public health.
This vaccine delivery is not a one-time effort but part of a larger export agreement that anticipates further shipments in the coming months, underscoring the ongoing collaboration between Argentina and South Africa in the health and agricultural sectors. The response to this outbreak not only addresses immediate health concerns but also emphasizes the importance of global cooperation in managing agricultural diseases that can have significant economic ramifications for both countries.
